leucine has been researched along with Brain Inflammation in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (5.13) | 24.3611 |
2020's | 37 (94.87) | 2.80 |
Authors | Studies |
---|---|
Buganza, M; Cantalupo, G; Filipponi, S; Giometto, B; Pellegrini, M; Piffer, S; Poretto, V; Tanel, R | 1 |
Fan, C; Gao, L; Huang, X; Li, L; Shen, H; Ye, J | 1 |
Butzkueven, H; Monif, M; O'Brien, TJ; Seery, N | 1 |
Baudin, P; Charpier, S; Cousyn, L; Lecas, S; Lehongre, K; Mahon, S; Navarro, V; Roussel, D; Whitmarsh, S | 1 |
Li, G; Liu, X; Ren, J; Wang, M; Wang, Q; Yu, T | 1 |
Fujita, H; Shioda, M; Suzuki, K | 1 |
Cui, CS; Feng, F; Li, HY; Liu, XW; Qiao, S; Yang, XD | 1 |
Cai, HB; Kang, HC; Kirsch, HE; Li, C; Luo, HY; Tang, ZP; Xi, XC; Zhao, X; Zhou, Q | 1 |
Guan, H; Hou, L; Li, H; Ren, H; Wan, L; Wang, P; Wang, Z | 1 |
Aboseif, A; Galioto, R; Krishnan, K; Kunchok, A; Lace, J | 1 |
Banks, P; Blank, CU; Boehmerle, W; Compter, A; Endres, M; Enokida, T; French, LE; Gesierich, A; Hagenacker, T; Harvey, C; Hassel, JC; Heinzerling, LM; Huehnchen, P; Hundsberger, T; Kähler, KC; Knauss, S; Long, GV; Meier, F; Mohr, R; Müller-Jensen, L; Reinhardt, L; Salzmann, M; Schlaak, M; Schöberl, F; Seggewiss-Bernhardt, R; Soon, JA; Spain, L; Tahara, M; Ugurel, S; Versluis, JM; von Baumgarten, L; Zierold, S; Zimmer, L | 1 |
Annoni, JM; Meier, L; Petersen, JA; Weinrebe, W | 1 |
Chen, L; Chen, X; Chen, Y; Jiang, L; Li, X; Qiao, T; Wei, H; Xu, Y | 1 |
Hara, M; Kawazoe, T; Murayama, A; Nakajima, H; Sugaya, K; Takahashi, K; Tobisawa, S | 1 |
Angstwurm, K; Bergh, FT; Bien, CG; Bogarin, Y; Doppler, K; Finke, A; Geis, C; Gerner, ST; Handreka, R; Häusler, M; Hellwig, K; Kaaden, T; Kaufmann, M; Kellinghaus, C; Koertvelyessy, P; Kraft, A; Kunze, A; Lewerenz, J; Leypoldt, F; Madlener, M; Malter, M; Melzer, N; Menge, T; Mues, S; Paliantonis, A; Prüss, H; Rauer, S; Reimann, G; Ringelstein, M; Rostásy, K; Schirotzek, I; Schwabe, J; Sokolowski, P; Suesse, M; Sühs, KW; Surges, R; Tauber, SC; Thaler, F; Urbanek, C; von Podewils, F; Wandinger, KP; Wildemann, B; Zettl, U | 1 |
Anderyas, P; Halliday, A; Reardon, K | 1 |
Gao, N; Zhang, WJ | 1 |
Chen, J; Huo, T; Luo, X; Wang, T; Zhao, J | 1 |
Ching, E; Mohammed, H; Murdoch, H | 1 |
Karvigh, SA; Salehizadeh, S; Vahabizad, F | 1 |
Cui, T; Hogan, RE; Li, G; Liu, X; Lv, R; Wang, Q; Yu, T | 1 |
Jin, Y; Li, HY; Liu, XW; Qiao, S; Wang, AH; Wang, ZH; Zhang, SC | 1 |
Bittner, D; Düzel, E; Goihl, A; Korte, M; Körtvélyessy, P; Leypoldt, F; Ludewig, S; Reinhold, D; Rohne, J; Salzburger, L; Schraven, B | 1 |
Li, H; Li, J; Li, L; Wang, S; Wang, Y; Zhao, X | 1 |
Chae, JH; Jang, S; Kim, KJ; Kim, SY; Kim, WJ; Lim, BC | 1 |
Chen, X; Deng, B; Ge, J; Jin, L; Liu, X; Tang, W; Wang, J; Xue, L; Yu, H; Zhang, X; Zuo, C | 1 |
Chen, L; Liu, Y; Su, T | 1 |
Qu, G; Wang, S; Wang, Y; Yu, X; Zhao, J | 1 |
Barwick, T; Dixon, L; Jesuthasan, A; Johnson, MR; Molloy, S; Tomlinson, JAP | 1 |
Abbatemarco, JR; Aboseif, A; Amin, M; Cohen, JA; Galioto, R; Kunchok, A; Lapin, B; Li, Y; Milinovich, A; Punia, V; Rae-Grant, AD | 1 |
Çarçak, N; Korkmaz, HY; Küçükali, CI; Onat, F; Pişkin, ŞA; Şanlı, E; Tüzün, E; Ulusoy, CA | 1 |
Liu, W; Liu, Y; Liu, Z; Ryuji, S; Shao, M | 1 |
Guo, D; Liang, J; Liu, L; Ma, H; Man, X; Sun, J; Tao, S; Yuan, X; Zhang, J | 1 |
Li, JH; Li, JM; Lu, H; Ma, XR; Peng, T | 1 |
Goto, J; Iwata, NK; Kawai, M; Murai, H; Nakajima, H; Orimo, K; Takeda, K | 1 |
Binks, SNM; Easton, A; Husain, M; Irani, SR; Leite, MI; Okai, D; Veldsman, M | 1 |
Chen, J; Guan, H; Huang, Y; Jin, L; Lin, N; Liu, Q; Lu, Q | 1 |
Gao, XY; Huang, Y; Liu, HQ; Shi, YY; Wang, CC; Wu, YY; Yang, HL; Zhang, JW; Zhang, YX | 1 |
Day, GS | 1 |
3 review(s) available for leucine and Brain Inflammation
Article | Year |
---|---|
Contemporary advances in antibody-mediated encephalitis: anti-LGI1 and anti-Caspr2 antibody (Ab)-mediated encephalitides.
Topics: Autoantibodies; Encephalitis; Glioma; Humans; Intracellular Signaling Peptides and Proteins; Leucine | 2022 |
Anti-leucine-rich glioma-inactivated 1 encephalitis: two case reports and a review of the literature.
Topics: Autoantibodies; Encephalitis; Female; Glioma; Humans; Intracellular Signaling Peptides and Proteins; Iran; Leucine; Limbic Encephalitis; Neoplasm Recurrence, Local; Seizures | 2022 |
Clinical characteristics of Leucine-rich glioma-inactivated protein 1 antibody-mediated autoimmune encephalitis in a 6-year-old girl: case report and literature reviews.
Topics: Autoimmune Diseases of the Nervous System; Child; Encephalitis; Female; Glioma; Humans; Hyponatremia; Leucine; Pain | 2023 |
36 other study(ies) available for leucine and Brain Inflammation
Article | Year |
---|---|
Agrypnia excitata as the main feature in anti-leucine-rich glioma-inactivated 1 encephalitis: a detailed clinical and polysomnographic semiological analysis.
Topics: Autoantibodies; Encephalitis; Glioma; Hashimoto Disease; Humans; Leucine; Limbic Encephalitis; Male; Middle Aged | 2022 |
Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.
Topics: Adrenal Cortex Hormones; Autoantibodies; Encephalitis; Female; Glioma; Humans; Hyponatremia; Immunologic Factors; Immunotherapy; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Male; Middle Aged; Seizures | 2022 |
Kv1.1 channels inhibition in the rat motor cortex recapitulates seizures associated with anti-LGI1 encephalitis.
Topics: Animals; Encephalitis; Glioma; Hashimoto Disease; Humans; Intracellular Signaling Peptides and Proteins; Leucine; Motor Cortex; Rats; Seizures | 2022 |
Predicting the functional outcomes of anti-LGI1 encephalitis using a random forest model.
Topics: Autoantibodies; Bayes Theorem; Encephalitis; Glioma; Humans; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Retrospective Studies | 2022 |
Anti-LGI1 encephalitis recurring 3 years after the first episode: a case report.
Topics: Aged; Autoantibodies; Contrast Media; Encephalitis; Gadolinium; Glioma; Humans; Hyponatremia; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Male; Methylprednisolone; Sodium | 2022 |
Clinical features and outcomes of leucine-rich glioma-inactivated protein 1 and contactin protein-like 2 antibody-associated autoimmune encephalitis in a Chinese cohort.
Topics: Autoantibodies; China; Contactin 2; Encephalitis; Female; Glioma; Hashimoto Disease; Humans; Intracellular Signaling Peptides and Proteins; Leucine; Male; Potassium Channels, Voltage-Gated; Retrospective Studies | 2022 |
What Is Different about Teratoma-Associated Anti-LGI1 Encephalitis? A Long-Term Clinical and Neuroimaging Case Series.
Topics: Autoantibodies; Dementia; Encephalitis; Female; Glioma; Humans; Hyponatremia; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Neuroimaging; Status Epilepticus | 2022 |
Persistent hiccup as one of the initial symptoms of leucine-rich glioma-inactivated-1 encephalitis: a case report.
Topics: Autoantibodies; Encephalitis; Glioma; Hiccup; Humans; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Male; Middle Aged; Seizures | 2022 |
Cognitive outcomes in anti-LGI-1 encephalitis.
Topics: Adult; Aged; Cognition; Cognitive Dysfunction; Encephalitis; Epilepsy, Temporal Lobe; Female; Humans; Intracellular Signaling Peptides and Proteins; Leucine; Male; Neuropsychological Tests; Retrospective Studies | 2023 |
Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study.
Topics: Autoantibodies; Cohort Studies; Encephalitis; Glioma; Herpesvirus 1, Human; Humans; Immune Checkpoint Inhibitors; Intracellular Signaling Peptides and Proteins; Leucine; Retrospective Studies | 2022 |
Confusion and Hallucination in a Geriatric Patient. Pitfalls of a Rare Differential: Case Report of an Anti-LGI1-Encephalitis.
Topics: Aged; Anticonvulsants; Confusion; Dementia; Encephalitis; Female; Hallucinations; Hashimoto Disease; Humans; Immunoglobulins, Intravenous; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Potassium Channels, Voltage-Gated; Rituximab; Seizures | 2022 |
Case Report: Paroxysmal hyperhidrosis as an initial symptom in a patient with anti-LGI1 encephalitis.
Topics: Anticonvulsants; Dyskinesias; Encephalitis; Glioma; Humans; Hyperhidrosis; Immunoglobulins, Intravenous; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Male; Middle Aged; Steroids | 2022 |
Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2.
Topics: Autoantibodies; Contactins; Encephalitis; Humans; Intracellular Signaling Peptides and Proteins; Isaacs Syndrome; Leucine; Limbic Encephalitis | 2023 |
Seizure Semiology in Antibody-Associated Autoimmune Encephalitis.
Topics: Autoantibodies; Encephalitis; Glutamate Decarboxylase; Humans; Intracellular Signaling Peptides and Proteins; Leucine; Prospective Studies; Receptors, N-Methyl-D-Aspartate; Seizures; Status Epilepticus | 2022 |
Anti-LGI1-Associated Myopathy in the Setting of Neuromuscular Hyperexcitability Syndrome.
Topics: Autoantibodies; Encephalitis; Humans; Leucine; Limbic Encephalitis; Muscular Diseases | 2022 |
Anti-Leucine-rich glioma-inactivated Protein 1 antibody-associated encephalitis complicated by minimal change nephrotic syndrome: a case report.
Topics: Adrenal Cortex Hormones; Autoantibodies; Encephalitis; Glioma; Humans; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Nephrosis, Lipoid | 2022 |
A Chinese female patient with LGI1 and mGluR5 antibodies: A case report.
Topics: Aged; Autoantibodies; China; Encephalitis; Female; Glioma; Humans; Intracellular Signaling Peptides and Proteins; Ischemic Stroke; Leucine; Limbic Encephalitis; Seizures | 2022 |
Leucine-rich glioma-inactivated 1 antibody encephalitis as a rare cause of delirium.
Topics: Delirium; Encephalitis; Glioma; Humans; Leucine | 2022 |
Prognostic significance and extra-hypothalamus dysfunction of hyponatremia in anti-leucine-rich glioma-inactivated protein 1 encephalitis.
Topics: Encephalitis; Glioma; Humans; Hyponatremia; Leucine; Prognosis | 2022 |
Cytokines/chemokines and immune checkpoint molecules in anti-leucine-rich glioma-inactivated 1 encephalitis.
Topics: Autoantibodies; Chemokines; Cytokines; Encephalitis; Glioma; Humans; Immune Checkpoint Proteins; Intracellular Signaling Peptides and Proteins; Leucine | 2023 |
Antibody Properties Associate with Clinical Phenotype in LGI1 Encephalitis.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Autoantibodies; Encephalitis; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Mice; N-Methylaspartate; Phenotype; Seizures | 2023 |
CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis.
Topics: Autoantibodies; Biomarkers; Chitinase-3-Like Protein 1; Chitinases; Encephalitis; Glioma; Humans; Leucine; Limbic Encephalitis | 2022 |
A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure.
Topics: Adult; Autoantibodies; Child; Dyskinesias; Encephalitis; Female; Glioma; Humans; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Methylprednisolone; Seizures | 2023 |
Characterization of neuroinflammation pattern in anti-LGI1 encephalitis based on TSPO PET and symptom clustering analysis.
Topics: Autoimmune Diseases of the Nervous System; Encephalitis; Glioma; Humans; Intracellular Signaling Peptides and Proteins; Leucine; Neuroinflammatory Diseases; Positron-Emission Tomography; Receptors, GABA; Seizures | 2023 |
Leucine-rich glioma-inactivated protein 1 antibody-associated encephalitis in a 22-month-old girl: a case report.
Topics: Autoantibodies; Autoimmune Diseases of the Nervous System; Encephalitis; Female; Glioma; Humans; Immunosuppressive Agents; Infant; Intracellular Signaling Peptides and Proteins; Leucine | 2023 |
LGI1 Encephalitis and IgG4-Related Disease: Rare Conditions Collide.
Topics: Autoantibodies; Encephalitis; Humans; Immunoglobulin G; Immunoglobulin G4-Related Disease; Intracellular Signaling Peptides and Proteins; Leucine | 2023 |
Clinical Determinants of Longitudinal Disability in LGI-1-IgG Autoimmune Encephalitis.
Topics: Aged; Autoimmune Diseases of the Nervous System; Encephalitis; Female; Humans; Immunoglobulin G; Leucine; Male | 2024 |
Antibody induced seizure susceptibility and impaired cognitive performance in a passive transfer rat model of autoimmune encephalitis.
Topics: Animals; Autoantibodies; Autoimmune Diseases of the Nervous System; Cognition; Encephalitis; Epilepsy; Glioma; Humans; Immunoglobulin G; Leucine; Rats; Rats, Wistar; Seizures | 2023 |
Anti-leucine-rich glioma-inactivated 1-positive limbic encephalitis presenting hypothalamic symptoms.
Topics: Autoantibodies; Encephalitis; Glioma; Humans; Leucine; Limbic Encephalitis; Proteins | 2020 |
Anti-leucine-rich Glioma Inactivated-1 Encephalitis Associated with Essential Thrombocythemia.
Topics: Adrenal Cortex Hormones; Autoantibodies; Encephalitis; Glioma; Hashimoto Disease; Humans; Hyponatremia; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Male; Middle Aged; Seizures; Thrombocythemia, Essential | 2020 |
[Clinical features and outcomes in relapsing and monophasic patients with anti-leucine-rich glioma-inactivated 1 encephalitis].
Topics: Autoantibodies; Encephalitis; Glioma; Humans; Leucine; Neoplasm Recurrence, Local; Retrospective Studies | 2020 |
Anti-LGI1 Encephalitis Developing Immunoglobulin Responsive Orthostatic Hypotension after Remission.
Topics: Aged; Autoantibodies; Encephalitis; Glioma; Humans; Hypotension, Orthostatic; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Male; Potassium Channels, Voltage-Gated | 2021 |
Residual Fatigue and Cognitive Deficits in Patients After Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis.
Topics: Antibodies; Autoantibodies; Cognition; Cognitive Dysfunction; Encephalitis; Fatigue; Glioma; Humans; Leucine | 2021 |
Long-term seizure outcomes in patients with anti-Leucine-rich glioma-inactivated 1 encephalitis.
Topics: Aged; Encephalitis; Glioma; Humans; Intracellular Signaling Peptides and Proteins; Leucine; Seizures | 2021 |
[Clinical analysis of 9 cases with Anti-leucine-rich glioma inactivated 1 protein antibody associated limbic encephalitis].
Topics: Antibodies; Autoantibodies; Encephalitis; Glioma; Humans; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Proteins; Seizures | 2017 |
Rethinking Outcomes in Leucine-Rich, Glioma-Inactivated 1 Protein Encephalitis: "Good" Isn't Good Enough.
Topics: Cognition; Encephalitis; Glioma; Hippocampus; Humans; Leucine | 2017 |